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ABSTRAK
Pengesanan awal risiko kanser payudara menggunakan mammografi dapat 
mengurangkan kos pengurusan rawatan dan prognosis penyakit ini. Paras 
ketumpatan payudara yang dikesan menggunakan mammogram memberi 
potensi faktor penyebab kepada risiko kanser payudara. Penghasilan sel epitelial 
pada mamari dapat ditentukan oleh faktor genetik. Gen transforming growth 
factor-beta (TGF-ß) telah dikenalpasti terlibat di dalam regulasi proliferasi sel dan 
pembahagian sel. Kajian ini bertujuan untuk mengukur hubung kait polimorfisme 
TGF-ß1 dengan ketumpatan payudara di kalangan wanita yang menjalani saringan 
mamografi. Pengesanan genotip bagi tiga polimorfisme TGF-ß1 yang dikenali 
sebagai rs1800469, rs1800470 dan rs4803455 dilakukan dengan teknik PCR-RFLP. 
Frekuensi alel dan genotip dikira bagi kumpulan kawalan yang terdiri dari kalangan 
wanita yang telah dikelaskan BIRADS 1 dan BIRADS 2, manakala kumpulan kes 
terdiri dari kalangan wanita yang telah dikelaskan BIRADS 3 dan BIRADS 4.Dua 
polimorfisme (rs1800469 dan rs1800470) telah menunjukkan hubung kait yang 
signifikan dengan ketumpatan payudara dengan nilai P= 0.004 dan 0.003. Namun 
begitu polimorfisme yang ketiga iaitu rs4803455 tidak menunjukkan hubung kait  
(nilai P=0.090). Analisa hubung kait  haplotaip mencadangkan haplotaip GAA 
berupaya memberi kecenderungan ketumpatan payudara (nilai P=0.02, OR=2.21 
[1.07-4.55]) berbanding haplotaip AAC yang berupaya untuk memberi kesan 
perlindungan dari penghasilan ketumpatan payudara (nilai P=0.004, OR=0.40 
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of radiation to chest area, dense 
breast detected on mammogram and 
genetic factor such as BRCA1 and 
BRCA2 gene mutation (Armstrong et 
al. 2000). Mutations in BRCA1 and 
BRCA2 are relatively uncommon that 
predispose a susceptibility to breast 
cancer development. Therefore, 
other genes might play a pivotal 
[0.21-0.77]). Data asas hubung kait dan haplotaip ini memberi penjelasan kaitan 
polimorfisme TGF-ß1 dengan ketumpatan payudara dan memberi maklumat fungsi 
polimorfisme di dalam mempengaruhi pembentukan ketumpatan payudara.
Kata kunci: asosiasi, ketumpatan payudara, polimorfisme, gen TGF-ß1
ABSTRACT
Early detection of breast cancer risk by screening tools such as mammography can 
reduces the cost of treatment management and the prognosis of the disease. The 
level of breast density of in mammogram is one of the potential cofounder factor 
for breast cancer risk. The development of mammary epithelial cells is determined 
by the genetic factor. Transforming growth factor-beta (TGF-ß) gene involves in 
the regulation of cell proliferation and cell division. This study aimed to assess the 
association of TGF-ß1 polymorphisms with breast density among women who 
underwent breast screening using mammogram. The detection of genotypes for 
three polymorphisms of TGF-ß1 assigned as rs1800469, rs1800470 and rs4803455 
were performed using PCR-RFLP technique. The allele and genotype frequencies 
were calculated for control group that consists of BIRADS 1 and BIRADS 2 class 
whilst case group consisted of BIRADS 3 and BIRADS 4 class. Two polymorphisms 
(rs1800469 and rs1800470) yielded a significant association with breast density 
with p value of 0.004 and 0.003, respectively. However, the third polymorphism, 
rs4803455 did not yield a significant association (p value=0.090). Haplotype 
association analysis might suggest the haplotype GAA conferred susceptibility (p 
value= 0.02, OR=2.21[1.07-4.55]) rather than haplotype AAC predispose a protective 
effect (p value=0.004, OR=0.40[0.21-0.77]) to breast density development. This 
preliminary data on single and haplotype association might reveal the association 
of polymorphisms of TGF-ß1 with breast density and give an insight on the role of 
polymorphism in predisposing to breast density development. 
Keywords: association, breast density, polymorphism, TGF-ß1 gene
INTRODUCTION
Breast carcinoma ranks second in all 
death due to cancer, worldwide and 
the first mortality factor in Malaysia. 
There are many cofounding factors 
that can lead to breast carcinoma. 
These include strong family history of 
breast carcinoma, patient with history 
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role in gene-gene networking and 
modify the risk of breast cancer (Ziv 
et al. 2001). The genetic entities that 
stimulate the mammary cell growth 
and proliferation determine the density 
of breast. Women with dense breasts 
showed a 1.8- to 6-fold increased risk 
of developing breast cancer (Boyd et 
al. 2002). Mammogram can assess 
density of the breast by relative amount 
of fat, connective tissue and epithelial 
cells determines the radiographic 
features of the breast on mammogram. 
Association of density percentage, 
dense areas with risk of breast cancer 
might reflect the potential associated 
genes in understanding the etiology 
and pathogenesis of breast cancer 
(Pettersson  et al. 2014). 
 In relation to the genetic factor 
contribution, the genetic entities are 
believed to determine the density of 
the breast that include TGF-ß gene. 
Transforming growth factor-beta 
(TGF-ß) is a cytokine that regulates the 
proliferation, cellular differentiation 
and other functions in the cell. The 
gene consists of three isoforms namely 
TGF-ß1, TGF-ß2 and TGF-ß3. The 
most isoform that upregulated in 
tumourgenesis is TGF-ß1 (Derynck 
et al. 2001). Defect in TGF-ß1 
pathway have been implicated in 
oncogenesis, particularly in breast 
cancer development. Transforming 
growth factors-ß (TGF-ßs) regulates 
mammary epithelial cell division. 
Loss of expression of TGF-ß receptor 
II (TGF-ß-RII) is related to cell 
proliferation and tumor progression 
in breast cancer (Gobbi et al. 1999). 
Joseph and colleagues have shown 
that TGF-ß promotes increased in 
ductal branching and resulted in 
alveolar hyperplasia of breast and 
premature functional differentiation 
(Joseph et al. 1999). Alterations in the 
TGF-ß pathway maybe due to mutation 
causing abnormal proliferation of the 
cells which is seen in human cancers 
(Elliot & Blobe 2005). TGF-ß has been 
reported to be involved in oncogenesis 
in transgenic mice where the deletion 
of one copy of the gene leads to 
increased cell turnover. However, 
the risk of mammary carcinoma 
was reduced when the expression 
of TGF-ß was increased (Pierce et 
al. 1995). There were a consistent 
reports that link to a functional TGF-ß1 
polymorphism with increased serum 
TGF-ß level to decreased breast cancer 
incidence in women in marked with 
decreased breast density (Ziv et al. 
2001). Thereby, the associated TGF-ß 
can be used to determine the risk of 
breast cancer in women. Association 
of TGF-ß is varies between different 
population group. There is paucity 
of study in Malaysia for determining 
the association of TGF-ß with the 
mammographic density. Thus,  this 
study was carried out.
MATERIALS AND METHODS
SUBJECTS RECRUITMENT
A total of 100 patients aged between 
40-65 years old who underwent 
the screening procedure of the 
mammogram at Hospital Sultanah 
Nur Zahirah were recruited and 
given informed consent in this study. 
An ethical clerance was obtained 
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from Universiti Sultan Zainal 
Abidin (UniSZA) Human Research 
Ethical Committee (No:UniSZA.C/1/
UHREC/628-1(38)) and National 
Medical Research Registry (No:NMRR 
15-1021-26292 (IIR). According to the 
BIRADS (breast imaging-reporting and 
data system) Classification. BIRADS 1 
(mostly fatty breast with 0-24% dense) 
and BIRADS 2 (scattered fibroglandular 
breast with 25-50% dense) with less 
breast dense were considered as 
control group (n=50) whilst BIRADS 3 
(heterogeneously dense breast with 51-
75% dense) and BIRADS 4 (extremely 
dense breast with 76-100% dense) with 
higher breast dense were considered 
as case group (n=50). The diagnosis on 
BIRADS classification was conducted 
by radiologists. Overall, SNPs give 
MAF of 0.35 with OR of 3 require 50 
samples for each case and control 
sample sets project a power of 97% 
(Johnson et al. 2001). This priori power 
calculation was based on the data 
generated by Hap Map database and 
Lee et al. (2013)  in Singapore Chinese 
women.
SNP GENOTYPING
An amount of 3 ml of peripheral blood 
was extracted for DNA according to 
the manufacturer’s protocol (Qiagen, 
Germany) and analyzed for TGF-ß 
polymorphisms using polymerase 
chain reaction-restriction fragment 
length polymorphism (PCR-RFLP) 
for three variants that were assigned 
as rs1800470 (A/G), rs1800469 
(G/A) and rs4803455 (C/A).The PCR 
pimers used for rs1800470 were5’-
AGCCACAGCAGCGGTAGCAGCAGT 
in the forward direction and 
5’-AGGACCTCAGCTTTCCCTCG 
in the reverse direction that results 
in cleavage of the 191 bp product 
into 31/160 bp fragments using Bst1; 
PCR pimers for rs1800469 were5’-
GGAGGGGGCAACAGGACACCTGC 
in the forward direction and 
5’-TGGGGGAGGATGGCACAGTG 
in the reverse direction that results in 
cleavage of the 289 bp product into 
30/259 bp fragments using HpyCH4V; 
and PCR primers used for rs4803455 
were5’-TTTGACACCCTGAATTCTCA 
in the forward direction and 
5’-TTAGTAGAGACGAGGTTTCAC 
in the reverse direction that results in 
cleavage of the 172 bp products into 
34/138 bp fragments using MluCI 
restriction enzymes. PCR technique 
was performed in a total of 25µl that 
consisted of 5X PCR buffer, 2.0mM 
MgCl2, 200mM dNTP, 0.2 mM of 
forward and reverse primer and 0.08 
U/µl of Taq polymerase (Promega, 
Madison, WI) before restriction 
enzyme digestion procedure. The PCR 
and PCR-RFLP product was preceded 
with 2% agarose gel electrophoresis 
and stained with ethidium bromide 
before viewed with the Alpha Imager 
Analyzer.
STATISTICAL ANALYSIS
Hardy-Weinberg equilibrium was 
calculated using SHEsis online  
software for cases and controls 
providing odd ratios (ORs) and 95% 
confidence interval (95%CI). Allelic 
and genotypic frequencies were 
compared between case and control 
sample sets. SHEsis online software 
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was also used to determine haplotype 
frequencies and to test for association 
of haplotypes with disease. Logistic 
regression analysis was used to 
correlate the breast density with TGF-ß 
polymorphisms.
RESULTS
The single association analysis yielded 
a significant association of rs1800469 
and rs1800470 with breast density 
with p value of 0.004 and 0.003, 
respectively. Odd ratio for rs1800470 
could not be calculated due to no 
variation in case group. Eventhough 
rs48033455 projected a fairly 
association with p value of 0.090 with 
breast density, the trend of association 
was towards protective manner as 
interpreted by odd ratio with 0.61 
[0.33-1.10]. Table 1 showed the allelic 
and genotype frequencies in the single 
association analysis.
 While performing further 
investigation, haplotype analysis was 
conducted to test the predisposing 
affect of haplotypes with breast density. 
A sequential SNP that was tested in 
this analysis is rs1800469, rs1800470 
and rs4803455. Haplotype GAA and 
AAC yieled a significant p value with 
0.020 and 0.004, respectively in a 
opposing manner of effect. Haplotype 
GAA conferred a susceptible effect as 
projected by odd ratio with 2.21 [1.07-
4.55] whilts protective haplotype was 
shown in allele combination with AAC 
(OR=0.40 [0.21-0.77]) as shown in 
Table 2.
DISCUSSION
Mammographic density measures 
the ratio of the amount of epithelial 
and stroma tissue to the amount of fat 
tissue in the breast in which the criteria 
has been used as strong predictor 
of breast cancer risk (McCormack 
& dos Santos Silva 2006). TGF-ß 
polymorphisms were shown to 
determine mammographic density in 
which the breast dense is considered 
as risk factor for breast cancer. The 
contribution from TGF-ß arise from 
its main function as cell proliferation, 
Table 1: Single association analysis of TGFbeta polymorphisms with breast density.
Genotype data Case-control analysis
SNP Homozygouswild type Heterozygous
Homozygous 
mutant type MAF
P 
value
OR [95% 
CI]
Rs1800469 29(58.0) 10(20.0) 11(22.0) 32(32.0) 0.004 2.30 [1.29-4.09]
16(32.0) 16(32.0) 18(36.0) 52(52.0)
Rs1800470 50(100.0) 0(0.0) 0(0.0) 0(0.0) 0.003 -
45(90.0) 2(4.0) 3(6.0) 8(8.0)
Rs48033455 21(42.0) 19(38.0) 10(20.0) 39(39.0) 0.090 0.61 [0.33-1.10]
29(58.0) 14(28.0) 7(14.0) 28(28.0)
*Case data is at the top line while control data is at the bottom line. MAF= Minor allele frequency. P value 
< 0.05 is considered significant in Pearson Chi Square.
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differentiation and division which 
regulate mammary development. 
Variation to the TGF-ß might alter the 
normal homeostasis and determine the 
density of the breast. According to the 
BIRADS classification, individuals with 
BIRADS 1 and BIRADS 2 consist of less 
breast dense detected and analysed 
by mammography whilst individuals 
with BIRADS 3 and BIRADS 4 are 
prone to predispose to breast cancer 
risk as the breast density is higher than 
BIRADS 1 & BIRADS 2. In an attempt 
to elucidate the role of TGF-ß1, two 
variants (rs1800469 and rs1800470) 
have shown their association with 
breast density according to the BIRADS 
clasification. A non-synonymous 
variant Leu10Pro substitution of 
rs1800470 and a promoter variant 
C509T of rs1800469 have been 
extensively studies in breast cancer 
risk. The minor allele of rs1800469 
was shown to increase risk by giving 
the odd ratio of 2.30 in this study. Even 
though the odd ratio from association 
analysis of rs1800470 could not be 
calculated due to no heterogeneity, 
the variant showed a significant 
association with breast density. The 
data was consistent with other studies 
that the minor allele from this variant 
was significantly associated with a 4% 
and 5% increased of breast cancer risk 
(Broeks et al. 2011; Qiu et al. 2010). 
The data also projected the relative 
risk was higher in Asians compared 
to Caucasians with OR=1.11 (Qiu et 
al. 2010). The minor allele from both 
variants were shown association with 
higher TGF-ß1 serum level in which this 
study did not performed (Grainger et 
al. 1999). The third variant, rs4803455 
was not significantly associated in this 
study with the minor allele conferred 
protective effect based on OR=0.61. 
The data was contradicted to Lee et al. 
(2013) in which the variant showed a 
fairly association with p value of 0.034 
among Singapore Chinese women and 
the association was observed among 
nulliparous women. The contradictory 
might be due to ethnicity factor in 
which the women in this study was 
majority among 98% Malays.
 Malay is the majority ethnic group 
(96.6%) in Terengganu that comprises 
of 54.7% in Malaysia, followed by 
Chinese 24.3%, Indian 7.3%, other 
Bumiputera 12.8% and others 0.9%. 
The incidence of breast cancer 
in Malaysia was highest among 
Table 2: Haplotype association analysis of TGFbeta polymorphisms with breast density
Allele 
combination Control group Case group P value OR [95%CI]
GGC 3(3.0) 0(0.0) 0.07 -
GGA 2(2.0) 0(41.5) - -
GAC 29.2(29.2) 41.5 (41.5) 0.08 1.67[0.93-3.00]
GAA 13.8(13.8) 26.5(26.5) 0.02 2.21[1.07-4.55]
AGC 3(3.0) 0(0.0) 0.07 -
AAC 36.8(36.8) 19.5(19.5) 0.004 0.40[0.21-0.77]
AAA 12.2(12.2) 12.5(12.5) 0.99 1.00[0.43-2.32]
*Alleles from left to right are rs1800469, rs1800470 and rs4803455, respectively.
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Chinese, followed by Indian and 
Malays. However, the incidence of 
breast cancer among Malay women 
in Malaysia was 27.2% (Malaysian 
National Cancer Registry Report 2007-
2011). The data may provide evidence 
of breast density among Malay 
women with predicting the breast 
cancer incidence rate in Terengganu, 
particularly. However, future study in 
different ethnic is worth to be taken 
into account.
 In the current study, the data 
postulated that individuals with a 
combination of GGA haplotypes 
were prone to predispose to higher 
breast dense (categorized as BIRADS 
3 and BIRADS 4). The susceptible 
allele from rs4803455 which is A 
allele might confer a strong effect to 
this haplotype. An allele change from 
haplotype GAC to GAA strengthen 
the predisposing effect to breast 
density with odd ratio with 2.21[1.07-
4.55]. However when haplotype GAC 
was changed to haplotype AAC, the 
allele A from rs1800470 conferred 
protection or reduced the breast 
density development as projected 
by odd ratio with 0.40[0.21-0.77]. 
Noteworthly allele A from rs4803455 
and allele A from rs1800470 are the 
mutant or rare allele. To the best of our 
nowledge, our study is the first study 
conducted in Malaysia in assessing the 
association of TGF-ß1 polymorphisms 
with breast density accoding to the 
BIRADS classification. Even though 
the limitation of this study may arise 
from small number of sample size, 
this preliminary data may provide 
several avenues of future research with 
polymorphisms interaction within the 
same gene or gene-gene interaction 
might provide more accuracy in 
prediction of breast cancer risk. 
Thus, the single association and 
haplotype analysis of TGF-ß can be 
as a determinant risk factor for breast 
carcinoma. This data can provide an 
information about the role of TGF-ß in 
Malaysian population. 
 Other limitation may arise from 
smaller sample size that requires larger 
cohort to be tested and investigated in 
unraveling the role of genetic variants 
in well-characterized population-
based study. Yet, this current study 
suggests that the variations of TGF- ß1 
might alter the normal homeostasis of 
mammary parenchymal cells that can 
be as a potential biomarker in breast 
cancer risk and may provide baseline 
information to other researchers in 
exploring more evidences in the role 
of TGF-ß1 variants in breast density.
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